Individuals with primary Sjögren’s disease who experience symptoms such as dry eyes, dry mouth, fatigue, or joint pain may qualify for a research study evaluating an investigational treatment.
Sjögren’s Disease Research Study
Age Range:
18 to 75
Gender:
Male and Female
Location:
New Port Richey
About the Study
Researchers are studying new approaches that may help reduce immune system activity and improve symptoms associated with Sjögren’s disease. This research study is evaluating telitacicept, an investigational medication given as a weekly injection, designed to target pathways involved in abnormal immune responses and potentially improve disease activity over time.
Qualifications
You may be able to join if you:
- Are 18 to 75 years of age
- Have been diagnosed with primary Sjögren’s disease
- Have active disease symptoms
- Are on stable background treatment (if applicable)
*Other qualifications may apply